Skip to main content
. 2018 Jun 1;13(6):e0198387. doi: 10.1371/journal.pone.0198387

Fig 3. Cumulative three-year survival rate.

Fig 3

Data were estimated using the Kaplan–Meier approach, and the differences in the survival rate between the pre-end-stage renal disease pay-for-performance (P4P) and Non-P4P groups were compared using the log-rank test.